Your browser doesn't support javascript.
loading
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
Okita, Riki; Maeda, Ai; Shimizu, Katsuhiko; Nojima, Yuji; Saisho, Shinsuke; Nakata, Masao.
Afiliação
  • Okita R; Department of General Thoracic Surgery, Kawasaki Medical School, Matsushima 577, Kurashiki, 7010192, Japan.
  • Maeda A; Department of General Thoracic Surgery, Kawasaki Medical School, Matsushima 577, Kurashiki, 7010192, Japan.
  • Shimizu K; Department of General Thoracic Surgery, Kawasaki Medical School, Matsushima 577, Kurashiki, 7010192, Japan.
  • Nojima Y; Department of General Thoracic Surgery, Kawasaki Medical School, Matsushima 577, Kurashiki, 7010192, Japan.
  • Saisho S; Department of General Thoracic Surgery, Kawasaki Medical School, Matsushima 577, Kurashiki, 7010192, Japan.
  • Nakata M; Department of General Thoracic Surgery, Kawasaki Medical School, Matsushima 577, Kurashiki, 7010192, Japan.
Cancer Immunol Immunother ; 66(7): 865-876, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28341875

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Receptor ErbB-2 / Antígeno B7-H1 / Receptores ErbB / Neoplasias Pulmonares Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Receptor ErbB-2 / Antígeno B7-H1 / Receptores ErbB / Neoplasias Pulmonares Idioma: En Ano de publicação: 2017 Tipo de documento: Article